Valene Garr Barry

Mrs. Valene Garr Barry

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2018 in Clinical Nutrition ESPEN
Verified
Journal Article
Closed access
BWBrooks C. Wingo
Brooks C. Wingo
VBValene Garr Barry
Valene Garr Barry
AEAmy C. Ellis
Amy C. Ellis
BGBarbara Gower
Barbara Gower

31 January 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
VBValene Garr Barry
Valene Garr Barry
MSMariah Stewart
Mariah Stewart
TSTaraneh Soleymani
Taraneh Soleymani
RDRenee A. Desmond
Renee A. Desmond
AGAmy Goss
Amy Goss
BGBarbara Gower
Barbara Gower
The objective of this study is to determine whether middle-aged adults prescribed a low carbohydrate-high fat (LCHF) or low fat (LF) diet would have greater loss of central fat and to determine whether the insulin resistance (IR) affects intervention response. A total of 50 participants (52.3 ± 10.7 years old; 36.6 ± 7.4 kg/m2 BMI; 82% female) were prescribed either a LCHF diet (n = 32, carbohydrate: protein: fat of 5%:30%:65% without calorie restriction), or LF diet (n = 18, 63%:13–23%: 10–25% with calorie restriction of total energy expenditure—500 kcal) for 15 weeks. Central and regional body composition changes from dual-x-ray absorptiometry and serum measures were compared using paired t-tests and ANCOVA with paired contrasts. IR was defined as homeostatic model assessment (HOMA-IR) > 2.6. Compared to the LF group, the LCHF group lost more android (15.6 ± 11.2% vs. 8.3 ± 8.1%, p < 0.01) and visceral fat (18.5 ± 22.2% vs. 5.1 ± 15.8%, p < 0.05). Those with IR lost more android and visceral fat on the LCHF verses LF group (p < 0.05). Therefore, the clinical prescription to a LCHF diet may be an optimal strategy to reduce disease risk in middle-aged adults, particularly those with IR.

VBValene Garr Barry
Valene Garr Barry
SMSamantha L. Martin
Samantha L. Martin
PCPaula Chandler-Laney
Paula Chandler-Laney
ECEbony B. Carter
Ebony B. Carter
CSCamille R. Schneider-Worthington
Camille R. Schneider-Worthington
Postpartum fat mass (FM) and fat-free mass (FFM) may be informative predictors of future disease risk among women; hence, there is growing use of bioelectrical impedance analysis (BIA) to quantify FFM and FM among postpartum women due to the quick, non-invasive, and inexpensive nature of BIA. Despite this, very few studies have examined BIA’s performance, and it remains unclear as to whether specific BIA equations are needed for postpartum women. To explore these questions, we measured total body FFM and FM with a multi-frequency, segmental BIA, and dual-X-ray absorptiometry (DXA) in (1) women at one and four months postpartum (n = 21); and (2) height- and weight-matched non-postpartum women (controls, n = 21). BIA was compared to DXA using Deming regression models, paired t-tests, and Bland–Altman plots. Between-group comparisons were performed using an analysis of variance models. The mean difference between DXA and BIA was 1.2 ± 1.7 kg FFM (p < 0.01) and −1.0 ± 1.7 kg FM (p < 0.05) in postpartum women at both time points. The measurements of longitudinal changes in FFM and FM were not significantly different between BIA and DXA. Furthermore, there was no significant difference in BIA’s performance in postpartum vs. non-postpartum women (p = 0.29), which suggests that population-specific equations are not needed for postpartum women. The results of this study suggest that BIA is a suitable method to assess postpartum body composition among women at one and four months postpartum, using existing age-, race-, and sex-adjusted equations.

3 October 2020 in Obesity
Verified
Journal Article
Closed access
PDF file
VBValene Garr Barry
Valene Garr Barry
CPCourtney Peterson
Courtney Peterson
BGBarbara A. Gower
Barbara A. Gower

VBValene Garr Barry
Valene Garr Barry
JCJasmine Chiang
Jasmine Chiang
KBKaylan G. Bowman
Kaylan G. Bowman
KJKristina D. Johnson
Kristina D. Johnson
BGBarbara Gower
Barbara Gower
Membrane capacitance (CM), a bioimpedance-derived measure of cell membrane health, has been suggested as an indicator of health status. However, there are few published data to support its use in clinical settings. Hence, this study evaluated clinically relevant sources of variation, precision, and reliability of CM measurements. This longitudinal study included 60 premenopausal women. Sources of variability (e.g., demographics, body composition, serum measures, diet) were identified by stepwise regression. Precision and reliability were assessed by the coefficient of variation (CV), intraclass correlation coefficients (ICC), and technical error of the measurement (TEM) for intra-day (30 min apart) and inter-day measurements (7–14 days apart). Body composition, temperature, and metabolic activity were identified as sources of variability. CM measurements had high precision (CV = 0.42%) and high reliability for intra-day (ICC = 0.996) and inter-day (ICC = 0.959) measurements, independent of menstrual cycle and obesity status. Our results showed that CM measurements are sensitive to clinical factors and have high precision and reliability. The results of this study suggest that CM is sufficiently reliable for health status monitoring in conditions with variation in body composition, metabolic activity, or body temperature among premenopausal women.

14 August 2025 in Sensors
Verified
Journal Article
Open access
PDF file
Mitchell ZaplatoschMitchell Zaplatosch
Mitchell Zaplatosch
JMJuliana Fernandes Filgueiras Meireles
Juliana Fernandes Filgueiras Meireles
JAJaneen Amason
Janeen Amason
Sadaf DabeerSadaf Dabeer
Sadaf Dabeer
BKBrian Kliszczewicz
Brian Kliszczewicz
KIKatherine Heimburger Ingram
Katherine Heimburger Ingram
Background: Multifrequency bioelectrical impedance devices such as the InBody 770 (IB770) offer faster measurements and lower costs compared with other body composition assessments. This study validated measures from IB770 against the deuterium oxide dilution technique (D2O) and DXA and compared a four-compartment (4C) model using total body water (TBW) derived from IB770 compared with D2O. Methods: A total of 55 adult females (mean ± SD, age: 21.1 ± 2.6 years) completed IB770 and DXA scans and the D2O protocol. Lin’s concordance correlation coefficients (CCCs), Bland–Altman analyses, and other equivalence tests evaluated agreement between IB770 and the criterion for measures of fat mass (FM), fat-free mass (FFM), and TBW individually and as part of 4C models. Results: There was substantial agreement between IB770 and D2O for TBW (MD = Mean Difference) (MD = 0.34 L, CCC = 0.98) and between the IB770 and DXA for FM (MD = −0.22 kg, CCC = 0.99). IB770 overestimated FFM compared with DXA (MD = 3.15 kg, CCC = 0.91). Both 4C models had almost perfect agreement for FM (CCC = 0.99), FFM (CCC = 0.99), and body fat percentage (CCC = 0.99). Conclusions: IB770 is valid for assessing TBW and can be used within the context of a 4C model in females.